Group 1 - The company has obtained a mining license for the Itwen Chahanxi C5 polymetallic iron mine, which is crucial for its sustainable development in the iron resource sector [1][4] - The mine has a resource volume of 20.07 million tons with an average grade of 31.59% iron, along with associated metals including 76,100 tons of copper, 60,400 tons of zinc, and 2.86 tons of gold [1] - This license acquisition is expected to enhance the company's risk resilience and market competitiveness, positively impacting its long-term development [1] Group 2 - The mining license is valid from November 26, 2025, to November 25, 2044, covering an area of 9.3126 square kilometers [4] - The company operates as a state-owned enterprise and is positioned as a platform for iron resource integration within the province [1][4]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示 登录新浪财经APP 搜索【信披】查看更多考评等级 二、本次股份质押情况 公司近日接到控股股东通运投资通知，通运投资为质押给自然人朱宇超的本公司2,160,000股股份办理了 质押登记手续，具体事项如下： 1.本次股份质押基本情况 ● 大连百傲化学股份有限公司（以下简称"公司"）控股股东大连通运投资有限公司（以下简称"通运投 资"）持有公司股份总数为211,581,520股，占公司总股本的29.96%。截至本公告日，通运投资累计质押 的公司股份数为20,160,000股，占其持有公司股份总数的9.53%，占公司总股本的2.85%。 一、本次股份解除质押情况 公司近日收到控股股东通运投资关于股份解除质押的通知，通运投资为其质押给国联民生证券股份有限 公司（原名：国联证券股份有限公司）的28,000,000股公司股份办理了证券质押解除手续，本次解除质 押股份占公司总股本的3.96%。具体情况如下： ■ 注：本公告中合计数与各明细数直接相加之和在尾数上存在差异系由于四舍五入 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 公司于2025年12月18日获悉股东力鸿公司所持有本公司的部分股份被质押，具体情况如下： 1.本次股份质押基本情况 ■ 2.力鸿公司本次质押的股份不存在用作重大资产重组业绩补偿等事项的担保或其他保障用途的情况。 3.股东累计质押股份情况 截至公告披露日，上述股东及其一致行动人累计质押股份情况如下： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 广东迪生力汽配股份有限公司（以下简称"公司""迪生力"）控股股东江门力鸿投资有限公司（以下简 称"力鸿公司"）持有公司股份数量115,062,100股，占公司总股本26.87%，力鸿公司本次质押股份 18,120,000股，占其持股总数的15.75%，占公司总股本的4.23%。本次质押完成后，其累计质押公司股 份54,120,000股，占其持股总数的47.04%，占公司总股本的12.64%。 ● 力鸿公司本次股份质押所融资金主要用于其自身资金需求，本次股份质押不会导致公司控制权或控股 股东发生变更，不会对上市公 ...

Investment Overview - The company, WuXi AppTec Healthcare Holding S.C.S.p, has signed a Subscription Agreement to invest €10 million (approximately ¥82.76 million) in the Jeito II S.L.P. private equity fund, representing 1.07% of the fund's total raised shares [2][4] - After the completion of the Subscription Agreement and Transfer Agreement, WuXi Lux Holding will hold a total of €30 million in A-class shares, accounting for approximately 3.22% of the total raised fund [3][8] - This investment does not require approval from the company's board of directors or shareholders and does not constitute a related party transaction or a major asset restructuring as defined by regulations [2][3] Fund Management and Structure - The investment fund is established under French law, targeting innovative companies in the biopharmaceutical sector with significant clinical needs and commercialization potential [8][15] - The fund's total size is capped at €1.2 billion, with approximately €931 million raised to date [8] - The fund's management team, Jeito Capital S.A.S., is noted for its professional investment management capabilities and compliance with local laws [4][6] Investment Strategy and Goals - The fund aims to invest in 14 to 17 early-stage medical innovation startups, focusing on biopharmaceutical companies [15][16] - The expected return model is based on asset appreciation after deducting management fees [16] - The fund will enter a liquidation phase at the end of its term, with a structured process for asset realization and distribution to investors [17] Impact on the Company - The investment is expected to enhance the company's understanding of developments in the European biopharmaceutical sector, which is a key potential customer base [19] - The company believes that the management team's experience and resources will provide critical growth capital and operational guidance to European biopharmaceutical startups [19] - The investment will not significantly impact the company's financial status or operational results, as it is made with the company's own funds while ensuring sufficient capital for daily operations [19]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 截至2025年12月18日，公司控股股东高博投资（香港）有限公司合计持有公司股份9,201.92万股，占 公司总股本的31.53%，累计质押公司股份4,600万股，占其所持公司股份的49.99%，占公司总股本的 15.76%。 特此公告。 广州维力医疗器械股份有限公司 广州维力医疗器械股份有限公司（以下简称"公司"）于2025年12月18日接到公司控股股东高博投资（香 港）有限公司（以下简称"高博投资"）函告，获悉其近期将持有的本公司部分股份办理了质押登记手 续，具体事项如下: 一、本次股份质押基本情况 ■ 二、本次质押股份不涉及用作重大资产重组业绩补偿等事项的担保或其他保障用途的情况。 三、累计质押股份情况 截至本公告披露日，高博投资及其一致行动人累计质押股份情况如下： ■ 四、其他说明 本次股票质押不会导致高博投资对公司实际控制权的变更。高博投资具备良好的资金偿还能力，有足够 的风险控制能力，目前不存 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 已履行的审议程序：烟台亚通精工机械股份有限公司（以下简称"公司"或"亚通精工"）于2025年3月4 日召开第二届董事会第十七次会议、第二届监事会第十七次会议，审议通过《关于使用暂时闲置募集资 金进行现金管理额度的议案》，同意公司在确保不影响募集资金投资项目实施及募集资金安全的前提 下，使用总额度不超过1.5亿元的暂时闲置募集资金进行现金管理。公司监事会发表了明确同意意见， 保荐机构对本事项出具了无异议的核查意见。本事项无需提交公司股东大会审议。 ● 风险提示：尽管公司选择的现金管理产品属于安全性高、流动性好的保本型理财产品，总体风险可 控，但金融市场受宏观经济的影响较大，不排除该项投资收益会受到市场波动的影响。 一、本次闲置募集资金现金管理概况 （一）本次现金管理的目的 为提高募集资金使用效率，在不影响公司募投项目资金需求和保障资金安全的情况下，公司合理利用暂 时闲置募集资金进行现金管理，提高资金使用效率，增加公司收益，不会影响公司主营业务的发展，公 司资金使 ...

浙江物产环保能源股份有限公司 第五届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 证券代码：603071 证券简称：物产环能 公告编号：2025-050 一、董事会会议召开情况 浙江物产环保能源股份有限公司（以下简称"公司"）第五届董事会第十七次会议于2025年12月18日在公 司会议室以现场结合通讯方式召开。本次会议通知于2025年12月15日以电子邮件等方式发出。本次会议 应出席董事11名，实际出席11名，部分高级管理人员列席会议。本次会议由董事长陈明晖先生主持召 开，会议召开符合《公司法》等法律法规及《公司章程》的规定，会议决议合法、有效。 二、董事会会议审议情况 (一)审议通过《关于2025年度中期利润分配方案的议案》 表决情况：同意11票，反对0票，弃权0票。 具体内容详见公司同日披露的《浙江物产环保能源股份有限公司关于2025年度中期利润分配方案的公 告》。 本议案尚需提交公司股东会审议。 (二)审议通过《关于2025年度关联交易执行情况及2026年度日常关联交易预计的议案》 表决结果 ...

Core Viewpoint - The company will hold an investor briefing on December 26, 2025, to discuss its Q3 2025 performance and financial results, allowing for interactive communication with investors [2][3][4]. Group 1: Meeting Details - The investor briefing is scheduled for December 26, 2025, from 16:00 to 17:00 [2][5]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online interactive format [2][4]. - Investors can submit questions from December 19 to December 25, 2025, through the Roadshow Center website or via the company's email [2][4][6]. Group 2: Participation Information - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [4][5]. - The company will address commonly asked questions during the briefing, ensuring transparency and engagement with investors [3][4].

Key Points - Shanghai Mingxin Guangchu Enterprise Management Co., Ltd. holds 25,314,077 shares of Shanghai Huguang Welding Group Co., Ltd., accounting for 7.76% of the company's total share capital [1] - The total number of shares pledged by Mingxin Guangchu amounts to 22,000,000 shares, which represents 86.91% of its holdings [1] - The percentage of shares mentioned is calculated based on the company's total share capital of 326,231,473 shares as of December 17, 2025, due to the conversion period of "Huguang Convertible Bonds" [1] - The company received notification on December 18, 2025, regarding the pledge of a portion of shares held by Mingxin Guangchu [1] - The pledged shares are not used as collateral for major asset restructuring performance compensation or other guarantees [1]

Group 1 - The company, Jiangsu Southern Precision Engineering Co., Ltd., has approved a proposal to apply for a comprehensive credit limit of up to RMB 50 million from banks for the year 2024 [1] - The comprehensive credit includes various financial services such as domestic and foreign currency working capital loans, bank acceptance bills, and commercial bill discounts [1] - The credit limit is valid for a maximum of three years from the date of the shareholders' meeting resolution [1] Group 2 - The company has applied for credit limits of RMB 5.9 million and RMB 12 million from the Industrial and Commercial Bank of China and China Construction Bank, respectively, to support the operations of its subsidiary, Jiangsu Southern Changsheng New Energy Technology Co., Ltd. [2] - The total credit limit applied for by the company and its consolidated subsidiaries amounts to RMB 38.9 million, which is within the approved limit by the shareholders' meeting [2] - The chairman of the company has the authority to sign legal contracts related to the credit matters and the finance department is responsible for handling the related procedures [2]